Related Experiment Video
Updated: Jul 19, 2026

Testing for Metacognitive Responding Using an Odor-based Delayed Match-to-Sample Test in Rats
Published on: June 18, 2018
Gatekeeping procedures in dose-response clinical trials based on the Dunnett test
Alex Dmitrienko1, Walt Offen, Ouhong Wang
1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. dmitrienko_alex@lilly.com
Abstract:
This paper discusses multiple testing procedures in dose-response clinical trials with primary and secondary endpoints. A general gatekeeping framework for constructing multiple tests is proposed, which extends the Dunnett test [Journal of the American Statistical Association 1955; 50: 1096-1121] and Bonferroni-based gatekeeping tests developed by Dmitrienko et al. [Statistics in Medicine 2003; 22:2387-2400]. The proposed procedure accounts for the hierarchical structure of the testing problem; for example, it restricts testing of secondary endpoints to the doses for which the primary endpoint is significant. The multiple testing approach is illustrated using a dose-response clinical trial in patients with diabetes. Monte-Carlo simulations demonstrate that the proposed procedure provides a power advantage over the Bonferroni gatekeeping procedure. The power gain generally increases with increasing correlation among the endpoints, especially when all primary dose-control comparisons are significant.
Related Concept Videos
Dose Response Curve: Conventional Versus Nonmonotonic
Dose-Response Relationship: Selectivity and Specificity
Dose-Response Relationship: Potency and Efficacy
Dose-Response Relationship: Overview
Dosage Regimen: Individualization
Dosage Regimens: Designs and Approaches
